
Friday, April 27, 2018 9:16:03 AM
During the recent legislative session in the Maryland legislature, a bill was passed to authorize the Maryland Medical Cannabis Commission to reopen the application process and grant several additional Medical Cannabis Grower and Processor licenses throughout the state. We will be working diligently over the next several months to complete the application process, identify key areas within the state of Maryland for suitable facilities, and engage horticulture experts, as well as seasoned medical operations personnel to position SNM to be awarded either one or both of these new license opportunities.
"SNM is excited to have become involved with industry experts in each stage of the medical cannabis arena, from grow operations all the way down to retail sales at the dispensary level," stated SNM CEO Troy Lowman, "the legal counsel we have retained to assist us with our Grower and Processing applications to the Maryland Medical Cannabis Commission has a proven track record of assisting their clients in acquiring various medical cannabis licenses." “It is very humbling to realize we will be a part of a rapidly developing industry that will help so many people achieve quality of life living while with cancer and so many other diseases,” says Lowman.
The process from application to becoming fully operational is expected to take approximately 365 days.
Contact Information
Troy Lowman, CEO
Phone (410)733-6551
Email: info@snmholdings.com
Safe Harbor for Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospect s and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commissions. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Liked By
Spread the love. Be the first to like this post!
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM
Aether Global Innovations Corp. Signs Strategic Partnership MOU with STA, a cutting-edge, innovative and bespoke technology solutions provider • AETHF • Sep 19, 2023 9:11 AM
From Instagram to High Times: Unpacking the Power of Vast User Networks • META • Sep 19, 2023 8:45 AM
Volcon, Inc. Announces Improved Debt Position and Strategic Cost Reduction • VLCN • Sep 18, 2023 9:34 AM